Clinical Trials
Therapeutic area
Study
N
Early Feasibility
Feasibility
Pivotal
Sites
Solid Tumors
Stage IV
Dose escalation study to evaluate the safety of Sarah Nanotechnology System, with Alternating Magnetic Field (AMF) application
Safety evaluation of Sarah Nanotechnology System, with Alternating Magnetic Field (AMF) application
40
15
Enrolling
Submitted
Ovarian
Breast
Liver
Safety and efficacy evaluation of Sarah Nanotechnology System, with Alternating Magnetic Field (AMF) application
40
20
20
Submission anticipated in 2026
Submission anticipated in 2026
Submission anticipated in 2026
